Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study Psychedelics Investing
Silo Wellness to Create a Psychedelic Pharmaceutical Manufacturing and Research Portfolio with Proposed Acquisition of Dyscovry Science Psychedelics Investing
Albert Labs: Treating Cancer-Related Distress With Psilocybin-Based Medication Psychedelics Investing
Optimi Health: Natural Psychedelic Wellness Alternatives Capitalizing Diverse Revenue Streams Psychedelics Investing
Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc. Psychedelics Investing
Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101 Pharmaceutical Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
